» Articles » PMID: 10470748

Enteral Nutrition-related Gastrointestinal Complications in Critically Ill Patients: a Multicenter Study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units

Overview
Journal Crit Care Med
Date 1999 Sep 2
PMID 10470748
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the frequency of gastrointestinal complications (GICs) in a prospective cohort of critically ill patients receiving enteral nutrition and to assess its effect on nutrient administration and its relationship to the patient's outcome.

Design: Multicenter, prospective cohort study.

Setting: Thirty-seven multidisciplinary intensive care units (ICUs) in Spain.

Patients: Prospective cohort of 400 consecutive patients admitted to the ICU and receiving enteral nutrition.

Interventions: Noninterventional, follow-up study.

Measurements And Main Results: Enteral nutrition-related GICs and their management were defined by consensus before data collection. A set of variables related to enteral nutrition administration and the presence of GICs was recorded. During the 1-month study period, 400 patients were enrolled, and a total of 3,778 enteral feeding days were analyzed. The mean time of enteral nutrition was 9.6+/-0.4 days. Mean elapsed time from ICU admission to the start of enteral feeding was 3.1+/-0.2 days. A total of 265 patients (66.2%) received a standard polymeric formula, and 132 (33.8%) received a disease-specific one. Enteral feeds were administered mainly through a nasogastric tube (91%). One or more GICs were presented by 251 patients (62.8%) during the feeding course. The frequency of each particular GIC was as follows: high gastric residuals, 39%; constipation, 15.7%; diarrhea, 14.7%; abdominal distention, 13.2%; vomiting, 12.2%; and regurgitation, 5.5%. Enteral nutrition withdrawal as a consequence of noncontrollable GICs occurred in 15.2% of patients. The volume ratio (expressed as the ratio between administered and prescribed volumes) was calculated daily and was used as an index of diet administration efficacy. Patients with GICs had a lower volume ratio than did patients without GICs (63.1+/-1.20% vs. 93.3+/-0.3%) (p < .001), a longer length of stay (20.6+/-1.2 vs. 15.2+/-1.3 days) (p < .01), and higher mortality (31% vs. 16.1%) (p < .001).

Conclusions: The frequency of enteral nutrition-related GICs in critically ill patients is high. High gastric residuals is the most frequent GIC. These complications decreased nutrient intake and, if persistent, could expose the patients to undernutrition. Enteral feeding gastrointestinal intolerance seems to have an evolutive effect in prolonging the ICU stay and increasing patient mortality.

Citing Articles

Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review.

Kano K, Yamamoto R, Yoshida M, Sato T, Nishita Y, Ito J Nutrients. 2025; 17(5).

PMID: 40077715 PMC: 11901663. DOI: 10.3390/nu17050845.


The Application and Mechanism Analysis of Enteral Nutrition in Clinical Management of Chronic Diseases.

Li Q, Wang J Nutrients. 2025; 17(3).

PMID: 39940308 PMC: 11820659. DOI: 10.3390/nu17030450.


Multivariate analysis of factors associated with the successful prediction of initial blind placement of a nasointestinal tube in the stomach based on X-ray imaging: a retrospective, single-center study.

Zheng Z, Wang J, Shao Z, Cai H, Lu L, Tang S BMC Gastroenterol. 2024; 24(1):284.

PMID: 39179985 PMC: 11342475. DOI: 10.1186/s12876-024-03363-z.


Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition.

Abenavoli L, Scarpellini E, Paravati M, Scarlata G, Boccuto L, Tilocca B Nutrients. 2023; 15(16).

PMID: 37630759 PMC: 10459644. DOI: 10.3390/nu15163569.


[The clinical impact of implementation of a nutritional treatment protocol in critically ill adults with SARS-CoV-2 infection].

Alos Zaragoza L, Cobo Del Prado Ciurlizza I, Solis Albamonte P, Gandia Llopis J, Rossello Chornet M, Romero Garcia C Rev Esp Anestesiol Reanim. 2023; .

PMID: 37363692 PMC: 10208262. DOI: 10.1016/j.redar.2022.11.004.